Following the March meeting of GMMMG, the formulary has been updated to reflect decisions made by the Clinical Reference Group (CRG) and Medicines and Guidelines Subgroup (MGSG). Changes include:
- Addition of NICE guidance and MHRA drug safety updates to formulary
- Insulin aspart biosimilar (Trurapi) added to formulary as the first choice rapid acting insulin analogue, as a GREEN drug
- Haloperidol 500 microgram tablets added to the DNP list (criterion 2)
- Berotralstat added to the RAG list as a RED drug
For full details of the changes, please see the Formulary Change Log.